ResearcherUniversity of California San DiegoActive in the last 2 years

Wenxue Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9228-6162; OpenAlex author ID A5023308455. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer. Last author DOI 10.1016/j.critrevonc.2025.105076 ↗
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Last author DOI 10.1016/j.canlet.2024.217350 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xuejun Guo · 1 shared paper, 2026 · strength 0.43
- Paper Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer. DOI 10.1016/j.critrevonc.2025.105076 ↗
Baofa Yu · 1 shared paper, 2025 · strength 0.42
- Paper Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. DOI 10.1016/j.canlet.2024.217350 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.